UniProt ID | PAWR_HUMAN | |
---|---|---|
UniProt AC | Q96IZ0 | |
Protein Name | PRKC apoptosis WT1 regulator protein | |
Gene Name | PAWR | |
Organism | Homo sapiens (Human). | |
Sequence Length | 340 | |
Subcellular Localization | Cytoplasm. Nucleus. Mainly cytoplasmic in absence of apoptosis signal and in normal cells. Nuclear in most cancer cell lines. Nuclear entry seems to be essential but not sufficient for apoptosis (By similarity). Nuclear localization includes nucleopl | |
Protein Description | Pro-apoptopic protein capable of selectively inducing apoptosis in cancer cells, sensitizing the cells to diverse apoptotic stimuli and causing regression of tumors in animal models. Induces apoptosis in certain cancer cells by activation of the Fas prodeath pathway and coparallel inhibition of NF-kappa-B transcriptional activity. Inhibits the transcriptional activation and augments the transcriptional repression mediated by WT1. Down-regulates the anti-apoptotic protein BCL2 via its interaction with WT1. Seems also to be a transcriptional repressor by itself. May be directly involved in regulating the amyloid precursor protein (APP) cleavage activity of BACE1.. | |
Protein Sequence | MATGGYRTSSGLGGSTTDFLEEWKAKREKMRAKQNPPGPAPPGGGSSDAAGKPPAGALGTPAAAAANELNNNLPGGAPAAPAVPGPGGVNCAVGSAMLTRAAPGPRRSEDEPPAASASAAPPPQRDEEEPDGVPEKGKSSGPSARKGKGQIEKRKLREKRRSTGVVNIPAAECLDEYEDDEAGQKERKREDAITQQNTIQNEAVNLLDPGSSYLLQEPPRTVSGRYKSTTSVSEEDVSSRYSRTDRSGFPRYNRDANVSGTLVSSSTLEKKIEDLEKEVVRERQENLRLVRLMQDKEEMIGKLKEEIDLLNRDLDDIEDENEQLKQENKTLLKVVGQLTR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MATGGYRTSS -----CCCCCCCCCC | 29.82 | 22199227 | |
6 | Phosphorylation | --MATGGYRTSSGLG --CCCCCCCCCCCCC | 16.44 | 22199227 | |
8 | Phosphorylation | MATGGYRTSSGLGGS CCCCCCCCCCCCCCC | 20.82 | 25159151 | |
9 | Phosphorylation | ATGGYRTSSGLGGST CCCCCCCCCCCCCCH | 17.26 | 23403867 | |
10 | Phosphorylation | TGGYRTSSGLGGSTT CCCCCCCCCCCCCHH | 37.11 | 23403867 | |
15 | Phosphorylation | TSSGLGGSTTDFLEE CCCCCCCCHHHHHHH | 26.74 | 23403867 | |
16 | Phosphorylation | SSGLGGSTTDFLEEW CCCCCCCHHHHHHHH | 33.39 | 23403867 | |
17 | Phosphorylation | SGLGGSTTDFLEEWK CCCCCCHHHHHHHHH | 26.84 | 23403867 | |
24 | Acetylation | TDFLEEWKAKREKMR HHHHHHHHHHHHHHH | 47.51 | 26051181 | |
95 | Phosphorylation | GVNCAVGSAMLTRAA CCCHHHCHHHHHCCC | 12.14 | - | |
99 | Phosphorylation | AVGSAMLTRAAPGPR HHCHHHHHCCCCCCC | 12.74 | - | |
108 | O-linked_Glycosylation | AAPGPRRSEDEPPAA CCCCCCCCCCCCCCC | 51.16 | 28411811 | |
108 | Phosphorylation | AAPGPRRSEDEPPAA CCCCCCCCCCCCCCC | 51.16 | 30266825 | |
116 | Phosphorylation | EDEPPAASASAAPPP CCCCCCCCCCCCCCC | 25.51 | 23663014 | |
118 | Phosphorylation | EPPAASASAAPPPQR CCCCCCCCCCCCCCC | 23.59 | 23663014 | |
146 | Methylation | SSGPSARKGKGQIEK CCCCCCCCCCCHHHH | 65.77 | 116253451 | |
148 | Ubiquitination | GPSARKGKGQIEKRK CCCCCCCCCHHHHHH | 51.15 | 24816145 | |
153 | Ubiquitination | KGKGQIEKRKLREKR CCCCHHHHHHHHHHH | 57.36 | 27667366 | |
162 | Phosphorylation | KLREKRRSTGVVNIP HHHHHHHHCCCCCCC | 33.28 | 25159151 | |
163 | Phosphorylation | LREKRRSTGVVNIPA HHHHHHHCCCCCCCH | 31.98 | 25159151 | |
177 | Phosphorylation | AAECLDEYEDDEAGQ HHHHHHHHCCCHHHH | 25.07 | 22322096 | |
211 | Phosphorylation | VNLLDPGSSYLLQEP HHHCCCCCCCCCCCC | 22.62 | 28102081 | |
212 | Phosphorylation | NLLDPGSSYLLQEPP HHCCCCCCCCCCCCC | 26.22 | 28102081 | |
213 | Phosphorylation | LLDPGSSYLLQEPPR HCCCCCCCCCCCCCC | 17.09 | 27642862 | |
221 | Phosphorylation | LLQEPPRTVSGRYKS CCCCCCCEECCCCCC | 25.46 | 28102081 | |
223 | Phosphorylation | QEPPRTVSGRYKSTT CCCCCEECCCCCCCC | 19.55 | 19651622 | |
226 | Phosphorylation | PRTVSGRYKSTTSVS CCEECCCCCCCCCCC | 16.90 | 22617229 | |
227 | Ubiquitination | RTVSGRYKSTTSVSE CEECCCCCCCCCCCH | 39.71 | 24816145 | |
227 | Methylation | RTVSGRYKSTTSVSE CEECCCCCCCCCCCH | 39.71 | 115974615 | |
228 | Phosphorylation | TVSGRYKSTTSVSEE EECCCCCCCCCCCHH | 28.16 | 25159151 | |
229 | Phosphorylation | VSGRYKSTTSVSEED ECCCCCCCCCCCHHH | 20.95 | 22322096 | |
230 | Phosphorylation | SGRYKSTTSVSEEDV CCCCCCCCCCCHHHH | 33.93 | 25159151 | |
231 | Phosphorylation | GRYKSTTSVSEEDVS CCCCCCCCCCHHHHH | 24.59 | 22322096 | |
233 | Phosphorylation | YKSTTSVSEEDVSSR CCCCCCCCHHHHHHC | 34.73 | 22322096 | |
233 | O-linked_Glycosylation | YKSTTSVSEEDVSSR CCCCCCCCHHHHHHC | 34.73 | 28411811 | |
238 | Phosphorylation | SVSEEDVSSRYSRTD CCCHHHHHHCCCCCC | 22.78 | 23403867 | |
238 | O-linked_Glycosylation | SVSEEDVSSRYSRTD CCCHHHHHHCCCCCC | 22.78 | 28411811 | |
239 | Phosphorylation | VSEEDVSSRYSRTDR CCHHHHHHCCCCCCC | 34.78 | 23403867 | |
241 | Phosphorylation | EEDVSSRYSRTDRSG HHHHHHCCCCCCCCC | 12.40 | 22817900 | |
242 | Phosphorylation | EDVSSRYSRTDRSGF HHHHHCCCCCCCCCC | 27.82 | 27251275 | |
252 | Phosphorylation | DRSGFPRYNRDANVS CCCCCCCCCCCCCCC | 18.13 | 23090842 | |
259 | Phosphorylation | YNRDANVSGTLVSSS CCCCCCCCCEEECHH | 26.35 | 19664994 | |
261 | Phosphorylation | RDANVSGTLVSSSTL CCCCCCCEEECHHHH | 19.24 | 29255136 | |
264 | Phosphorylation | NVSGTLVSSSTLEKK CCCCEEECHHHHHHH | 22.99 | 29255136 | |
265 | Phosphorylation | VSGTLVSSSTLEKKI CCCEEECHHHHHHHH | 21.62 | 29255136 | |
266 | Phosphorylation | SGTLVSSSTLEKKIE CCEEECHHHHHHHHH | 29.52 | 29255136 | |
267 | Phosphorylation | GTLVSSSTLEKKIED CEEECHHHHHHHHHH | 40.67 | 29255136 | |
271 | Acetylation | SSSTLEKKIEDLEKE CHHHHHHHHHHHHHH | 41.79 | 26051181 | |
277 | 2-Hydroxyisobutyrylation | KKIEDLEKEVVRERQ HHHHHHHHHHHHHHH | 64.21 | - | |
277 | Ubiquitination | KKIEDLEKEVVRERQ HHHHHHHHHHHHHHH | 64.21 | 29967540 | |
296 | Ubiquitination | LVRLMQDKEEMIGKL HHHHHCCHHHHHHHH | 38.39 | 29967540 | |
296 | 2-Hydroxyisobutyrylation | LVRLMQDKEEMIGKL HHHHHCCHHHHHHHH | 38.39 | - | |
296 | Acetylation | LVRLMQDKEEMIGKL HHHHHCCHHHHHHHH | 38.39 | 26051181 | |
302 | Ubiquitination | DKEEMIGKLKEEIDL CHHHHHHHHHHHHHH | 45.52 | 27667366 | |
302 | Acetylation | DKEEMIGKLKEEIDL CHHHHHHHHHHHHHH | 45.52 | 7374293 | |
304 | Ubiquitination | EEMIGKLKEEIDLLN HHHHHHHHHHHHHHC | 57.71 | 29967540 | |
325 | Ubiquitination | EDENEQLKQENKTLL HHHHHHHHHHHHHHH | 56.09 | 24816145 | |
325 | Acetylation | EDENEQLKQENKTLL HHHHHHHHHHHHHHH | 56.09 | 26051181 | |
329 | Ubiquitination | EQLKQENKTLLKVVG HHHHHHHHHHHHHHH | 39.53 | 23000965 | |
333 | Ubiquitination | QENKTLLKVVGQLTR HHHHHHHHHHHHHCC | 37.68 | 23000965 | |
333 | Malonylation | QENKTLLKVVGQLTR HHHHHHHHHHHHHCC | 37.68 | 26320211 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
163 | T | Phosphorylation | Kinase | PKA | - | Uniprot |
231 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
231 | S | Phosphorylation | Kinase | CK2A1 | P19139 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXO45 | P0C2W1 | PMID:24992930 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
163 | T | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PAWR_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SC5A7_HUMAN | SLC5A7 | physical | 15090548 | |
SC5A1_HUMAN | SLC5A1 | physical | 15090548 | |
AATF_HUMAN | AATF | physical | 14627703 | |
DAPK3_HUMAN | DAPK3 | physical | 12917339 | |
THAP1_HUMAN | THAP1 | physical | 12717420 | |
KPCZ_HUMAN | PRKCZ | physical | 8797824 | |
WT1_HUMAN | WT1 | physical | 8943350 | |
GRP78_HUMAN | HSPA5 | physical | 19632185 | |
SPSB4_MOUSE | Spsb4 | physical | 20561531 | |
SPSB2_MOUSE | Spsb2 | physical | 20561531 | |
KPCZ_HUMAN | PRKCZ | physical | 11755531 | |
SQSTM_HUMAN | SQSTM1 | physical | 11755531 | |
ACPH_HUMAN | APEH | physical | 22863883 | |
CAND1_HUMAN | CAND1 | physical | 22863883 | |
SYCC_HUMAN | CARS | physical | 22863883 | |
NIBL1_HUMAN | FAM129B | physical | 22863883 | |
H33_HUMAN | H3F3A | physical | 22863883 | |
IDE_HUMAN | IDE | physical | 22863883 | |
JMJD6_HUMAN | JMJD6 | physical | 22863883 | |
PPM1G_HUMAN | PPM1G | physical | 22863883 | |
GLYM_HUMAN | SHMT2 | physical | 22863883 | |
SNX2_HUMAN | SNX2 | physical | 22863883 | |
SNX6_HUMAN | SNX6 | physical | 22863883 | |
STAT1_HUMAN | STAT1 | physical | 22863883 | |
VPS29_HUMAN | VPS29 | physical | 22863883 | |
FBSP1_HUMAN | FBXO45 | physical | 24992930 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231 AND SER-233, ANDMASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-226; SER-228; THR-229AND SER-231, AND MASS SPECTROMETRY. |